Metraipolis › archive › dc_ebf37facd6f3
AI-Enabled Personalization of Semaglutide Therapy in Type 2 Diabetes: Systematic Review With an Integration Framework — Europe PMC PMID:41802231
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41802231
- DOI
- 10.2196/86960
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:28:56.322Z
- SHA-256 of the archived text
94534be5fed2117a9cb22ffb241ea2180b71982eb11ca1c91abc5267e5e08c5a- Stable URL of this page
https://metraipolis.com/documento/dc_ebf37facd6f3
How to cite
AI-Enabled Personalization of Semaglutide Therapy in Type 2 Diabetes: Systematic Review With an Integration Framework — Europe PMC PMID:41802231 — Europe PMC (en), https://europepmc.org/article/MED/41802231 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebf37facd6f3 (Metraipolis archive dc_ebf37facd6f3, sha256 94534be5fed2117a9cb22ffb241ea2180b71982eb11ca1c91abc5267e5e08c5a)
BibTeX
@misc{dcebf37facd6f3,
title = {AI-Enabled Personalization of Semaglutide Therapy in Type 2 Diabetes: Systematic Review With an Integration Framework — Europe PMC PMID:41802231},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41802231},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebf37facd6f3; sha256 94534be5fed2117a9cb22ffb241ea2180b71982eb11ca1c91abc5267e5e08c5a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41802231. Agents can read the archived copy with the MCP tool read_document.